Latest / GNN Daily Breaking News / US states label abortion drugs a 'public nuisance' in bid to curb access

Transcript

US states label abortion drugs a 'public nuisance' in bid to curb access · GNN Daily Breaking News

• 0:00
  Speaker 1: State attorneys general in jurisdictions with strict reproductive health care
• 0:04
  Speaker 1: bans have launched an unprecedented legal strategy that characterizes out-of-state
• 0:09
  Speaker 1: mail-order abortion pill providers as public nuisances. By utilizing civil
• 0:14
  Speaker 1: nuisance doctrines traditionally reserved for environmental hazards, illicit drug operations,
• 0:20
  Speaker 1: and public safety threats, state prosecutors aim to block out-of-state
• 0:24
  Speaker 1: health care workers, telehealth networks, and digital pharmacies from shipping
• 0:29
  Speaker 1: prescription medications to local residents. The legal filings argue that
• 0:34
  Speaker 1: shield laws enacted by progressive states, which explicitly protect local
• 0:39
  Speaker 1: medical professionals from out-of-state prosecution, create an unlawful public nuisance
• 0:44
  Speaker 1: by deliberately undermining local statutory prohibitions designed to restrict medical
• 0:49
  Speaker 1: termination of pregnancy. State officials contend that out-of-state providers shipping
• 0:55
  Speaker 1: pharmaceuticals across regional borders infringe upon territorial sovereignty and violate
• 1:00
  Speaker 1: local public health regulations, asserting that state governments possess inherent
• 1:05
  Speaker 1: authority to abate activities deemed harmful to public safety and
• 1:09
  Speaker 1: civil order. This creative application of tort law highlights the
• 1:14
  Speaker 1: growing friction between states as telehealth services have increasingly emerged
• 1:18
  Speaker 1: as a primary avenue for obtaining reproductive care in regions
• 1:22
  Speaker 1: with near-total prohibitions. Following regional legislative rollbacks and statutory restrictions
• 1:29
  Speaker 1: across nearly half the country, remote consultation services and cross-border
• 1:34
  Speaker 1: delivery networks expanded rapidly to meet regional demand. In response,
• 1:39
  Speaker 1: anti-abortion advocacy groups and state legal officers are turning to
• 1:43
  Speaker 1: civil litigation mechanisms to hold out-of-state doctors and dispatch services
• 1:48
  Speaker 1: financially and legally accountable. The public nuisance approach seeks injunctions
• 1:53
  Speaker 1: and substantial monetary damages against providers. aiming to make interstate
• 1:58
  Speaker 1: pharmaceutical distribution financially unfeasible and force out-of-state medical networks to
• 2:04
  Speaker 1: cease serving patients in restrictive jurisdictions. Legal scholars and constitutional
• 2:09
  Speaker 1: experts note that using public nuisance law in this context
• 2:13
  Speaker 1: pushes traditional tort principles into unmapped constitutional territory, setting up
• 2:18
  Speaker 1: a major legal confrontation over interstate commerce and state jurisdiction.
• 2:23
  Speaker 1: Defense counsel representing health care providers and reproductive rights advocacy
• 2:28
  Speaker 1: organizations argue that applying public nuisance claims to federally approved
• 2:33
  Speaker 1: pharmaceuticals distributed through the mail represents an unconstitutional attempt to
• 2:38
  Speaker 1: extend state law beyond geographic borders. They maintain that federal
• 2:42
  Speaker 1: regulations governing mail services and interstate commercial transport preempt local
• 2:47
  Speaker 1: civil nuisance suits. warning that allowing states to restrict legally
• 2:52
  Speaker 1: prescribed out-of-state pharmaceuticals under the guise of public harm could
• 2:56
  Speaker 1: jeopardize broader access to various medical treatments nationwide. As higher
• 3:01
  Speaker 1: courts prepare to consider these jurisdictional clashes, the resolution of
• 3:06
  Speaker 1: public nuisance claims will heavily influence the future of interstate
• 3:10
  Speaker 1: medical privacy, telehealth delivery, and the reach of individual state authority.